Core Insights - Willis Towers Watson (WTW) is a leading global advisory, broking, and solutions company with a market cap of $32.8 billion, operating through two segments: Health, Wealth & Career, and Risk & Broking [1] Financial Performance - WTW is expected to report fiscal Q3 2025 earnings on October 30, with analysts predicting an adjusted EPS of $3, reflecting a 2.4% increase from $2.93 in the same quarter last year [2] - For fiscal 2025, adjusted EPS is forecasted at $16.83, a slight decline from $16.93 in fiscal 2024, but projected to grow 13.2% year-over-year to $19.05 in fiscal 2026 [3] Stock Performance - WTW shares have increased by 16.4% over the past 52 weeks, outperforming the S&P 500 Index's 13.1% gain and the Financial Select Sector SPDR Fund's 13.2% return [4] - On July 31, shares rose 4.6% following stronger-than-expected Q2 2025 results, with adjusted EPS of $2.86 and revenue of $2.26 billion, driven by a 7% revenue increase in the Risk & Broking unit to $1.05 billion [5] Analyst Ratings - The consensus view on WTW stock is cautiously optimistic, with a "Moderate Buy" rating from analysts; 12 recommend "Strong Buy," 1 "Moderate Buy," 9 "Hold," and 1 "Strong Sell" [6] - The average analyst price target for WTW is $373.84, indicating a potential upside of 9.4% from current levels [6]

Company Overview - International Paper Company (IP) has a market capitalization of $24.1 billion and is a global producer of renewable fiber-based packaging and pulp products, operating through its Industrial Packaging and Global Cellulose Fibers segments [1] Upcoming Earnings - The company is expected to release its fiscal Q3 2025 results on October 30, with analysts projecting an adjusted EPS of $0.53, representing a 20.5% increase from $0.44 in the same quarter last year [2] - For fiscal 2025, analysts forecast an adjusted EPS of $1.53, which is a 35.4% increase from $1.13 in fiscal 2024, and a further surge to $3.08 in fiscal 2026, marking a 101.3% year-over-year increase [3] Stock Performance - Over the past 52 weeks, shares of International Paper have declined by 5.2%, underperforming the S&P 500 Index, which gained 12.2%, but the decline is less severe than the Materials Select Sector SPDR Fund's 9.1% drop [4] - The stock experienced a significant drop of 12.9% on July 31 following disappointing Q2 2025 results, where adjusted EPS was reported at $0.20, falling short of analyst expectations due to increased input costs and muted demand in Europe [5] Analyst Ratings - Analysts maintain a cautiously optimistic view on IP stock, with a consensus "Moderate Buy" rating. Among 13 analysts, six recommend a "Strong Buy," one a "Moderate Buy," four suggest a "Hold," and two advise "Strong Sells." The average price target for the stock is $54.11, indicating a potential upside of 17.4% from current levels [6]

Core Viewpoint - Eastman Chemical Company (EMN) is facing significant challenges with declining earnings expectations and a substantial drop in share price over the past year, while analysts maintain a cautiously optimistic outlook on the stock's potential recovery [2][4][6]. Financial Performance - EMN is expected to report an adjusted EPS of $1.21 for fiscal Q3 2025, reflecting a 46.5% decline from $2.26 in the same quarter last year [2]. - For fiscal 2025, analysts forecast an adjusted EPS of $5.91, a decrease of 25.1% from $7.89 in fiscal 2024, but anticipate a recovery with a projected adjusted EPS of $6.97 in fiscal 2026, representing a year-over-year growth of 17.9% [3]. Stock Performance - Over the past 52 weeks, EMN shares have decreased by 45.7%, underperforming the S&P 500 Index, which gained 14.4%, and the Materials Select Sector SPDR Fund, which saw a nearly 8% decrease [4]. - Following the Q2 2025 results announcement, EMN shares fell over 19% after reporting an adjusted EPS of $1.60, which missed Wall Street's expectations, despite revenue of $2.29 billion meeting forecasts [5]. Analyst Sentiment - The consensus among analysts is a "Moderate Buy" rating for EMN, with eight out of 15 analysts recommending a "Strong Buy," two a "Moderate Buy," four a "Hold," and one a "Strong Sell" [6]. - The average analyst price target for Eastman Chemical is $74.40, indicating a potential upside of 23.9% from current levels [6].

Core Insights - Zimmer Biomet Holdings, Inc. (ZBH) has a market capitalization of $18.8 billion and specializes in orthopedic reconstructive products, sports medicine solutions, biologics, and surgical technologies, serving healthcare professionals globally [1] Financial Performance - The company is expected to announce its fiscal Q3 2025 results on November 5, with analysts predicting an adjusted EPS of $1.87, reflecting a 7.5% increase from $1.74 in the same quarter last year [2] - For fiscal 2025, adjusted EPS is projected to be $8.15, a 1.9% increase from $8 in fiscal 2024, with further growth anticipated to $8.42 in fiscal 2026, representing a 3.3% year-over-year increase [3] Stock Performance - Zimmer Biomet's shares have decreased by 7.9% over the past 52 weeks, underperforming the S&P 500 Index, which increased by 13.4%, and the Health Care Select Sector SPDR Fund, which declined by 7.6% during the same period [4] - Following the release of better-than-expected Q2 2025 results, shares rose nearly 8% on August 7, with adjusted EPS reported at $2.07 and revenue at $2.08 billion. The company also raised its 2025 adjusted EPS forecast to between $8.10 and $8.30, exceeding analyst expectations [5] Analyst Ratings - The consensus rating for ZBH stock is "Moderate Buy," with 27 analysts covering the stock: eight recommend "Strong Buy," two suggest "Moderate Buy," 15 give a "Hold" rating, and two have a "Strong Sell" rating. The average price target is $110.74, indicating a potential upside of 16% from current levels [6]

Core Insights - Norfolk Southern Corporation (NSC) has a market cap of $66.6 billion and operates one of the largest freight rail networks in the eastern United States, providing transportation for various commodities [1] Financial Performance - The company is expected to release its fiscal Q3 2025 results on October 23, with analysts projecting an adjusted EPS of $3.18, a 2.2% decline from $3.25 in the same quarter last year [2] - For fiscal 2025, adjusted EPS is forecasted to be $12.46, reflecting a 5.2% increase from $11.85 in fiscal 2024, with further growth projected to $13.97 in fiscal 2026, a 12.1% year-over-year increase [3] Stock Performance - NSC stock has increased nearly 22% over the past 52 weeks, outperforming the S&P 500 Index's 17.4% return and the Industrial Select Sector SPDR Fund's 14.8% gain during the same period [4] Market Sentiment - Despite a better-than-expected Q2 2025 adjusted EPS of $3.29, shares fell over 3% due to revenue of $3.11 billion missing estimates and concerns over rising operating expenses [5] - Analysts maintain a cautiously optimistic view on NSC stock, with a "Moderate Buy" rating from 21 analysts, including six "Strong Buy" and 15 "Hold" ratings, indicating a less bullish sentiment compared to three months ago [6] - The average analyst price target for Norfolk Southern is $310, suggesting a potential upside of 4.5% from current levels [6]

Core Insights - Principal Financial Group, Inc. (PFG) has a market capitalization of $18.8 billion and is a prominent global investment management company focusing on retirement, asset management, and insurance products and services [1] - The company is expected to report an adjusted EPS of $2.17 for fiscal Q3 2025, representing a 23.3% increase from $1.76 in the same quarter last year [2] - For fiscal 2025, analysts project an adjusted EPS of $8.28, indicating an 18.8% growth from $6.97 in fiscal 2024 [3] Stock Performance - Over the past 52 weeks, PFG shares have decreased by 3.6%, underperforming the S&P 500 Index, which gained 17.2%, and the Financial Select Sector SPDR Fund, which increased by 19.2% [4] - Following the release of better-than-expected Q2 2025 adjusted EPS of $2.16, the stock experienced a slight decline due to missing revenue estimates and a significant drop in Retirement and Income Solution revenues by 21.7% [5] Analyst Ratings - The consensus among analysts regarding PFG stock is cautious, with an overall "Hold" rating; out of 15 analysts, four recommend "Strong Buy," eight suggest "Hold," one indicates "Moderate Sell," and two have a "Strong Sell" rating [6] - The average analyst price target for Principal Financial is $86.23, suggesting a potential upside of 2.4% from current levels [6]

Core Insights - The Hartford Insurance Group, Inc. (HIG) has a market capitalization of $37.3 billion and offers a variety of insurance and financial services to individuals and businesses both domestically and internationally [1] Financial Performance - The company is expected to report an adjusted EPS of $3.04 for fiscal Q3 2025, representing a 20.2% increase from $2.53 in the same quarter of the previous year [2] - For fiscal 2025, analysts forecast an adjusted EPS of $11.65, which reflects a 13.1% rise from $10.30 in fiscal 2024 [3] - Following the release of Q2 2025 results, shares rose by 2.8% due to a 35% increase in quarterly profit, with net income available to common stockholders reaching $990 million or $3.44 per share, up from $733 million or $2.44 per share a year earlier [5] Market Performance - Over the past 52 weeks, shares of Hartford Insurance have increased by 12.2%, which is lower than the S&P 500 Index's gain of 17.2% and the Financial Select Sector SPDR Fund's return of 17.6% [4] Analyst Ratings - The consensus view on HIG stock is cautiously optimistic, with a "Moderate Buy" rating from analysts. Among 24 analysts, 10 recommend "Strong Buy," 2 suggest "Moderate Buy," and 12 indicate "Hold" [6] - The average analyst price target for Hartford Insurance is $139.70, suggesting a potential upside of 5.4% from current levels [6]

Core Insights - Westinghouse Air Brake Technologies Corporation (WAB) has a market cap of $34.2 billion and provides technology-based solutions for the freight rail and passenger transit industries [1] - Analysts forecast an adjusted EPS of $2.27 for fiscal Q3 2025, representing a 13.5% increase from the previous year [2] - For fiscal 2025, an adjusted EPS of $8.89 is expected, indicating a 17.6% growth from $7.56 in fiscal 2024 [3] Financial Performance - Wabtec's shares have increased by 10.9% over the past 52 weeks, underperforming the S&P 500 Index's 17.8% gain and the Industrial Select Sector SPDR Fund's 14.7% return [4] - Despite reporting a better-than-expected Q2 2025 adjusted EPS of $2.27, shares fell by 6.4% due to revenue of $2.71 billion missing estimates and a decline in Freight segment sales [5] Analyst Ratings - The consensus view on WAB stock is cautiously optimistic, with a "Moderate Buy" rating from 12 analysts, including seven "Strong Buy" and five "Hold" recommendations [6] - The average analyst price target for Wabtec is $222.60, suggesting a potential upside of 11.3% from current levels [6]

Group 1 - The company is preparing for Q4 fiscal year 2025, aiming to align all stakeholders before entering a silent period [1] - There has been a significant 6% devaluation of the U.S. dollar, which is expected to create negative translational headwinds on revenue for the full quarter [2] - The company anticipates that growth excluding foreign exchange effects will exceed nominal growth due to the currency fluctuations [2] Group 2 - The previous outlook for comparable revenue growth was set between 5.5% and 6%, with adjusted EPS expected to range from EUR 2.30 to EUR 2.45 [3] - Q4 is projected to be the strongest quarter in absolute terms, although it is expected to be less loaded compared to the previous year's Q4 [3]

Third Quarter 2025 Conference Call September 25, 2025 ® 2025 H.B. Fuller Title Slide Disclosure ® 2025 H.B. Fuller Third Quarter Highlights Adjusted EBITDA $171M Up 3% YOY Adjusted EBITDA Margin 19.1% Up 110 bps YOY Safe Harbor Statement Certain matters discussed today are forward-looking statements within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements reflect our ...